TickerFactsScreenerDevelopers

ANI PHARMACEUTICALS INC (ANIP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $11.76M2009: $29.86M2010: $38.16M2011: $02012: $11.0K2013: $11.11M2014: $169.04M2015: $154.68M2016: $27.36M2017: $31.14M2018: $43.01M2019: $62.33M2020: $7.86M2021: $100.30M2022: $48.23M2023: $221.12M2024: $144.86M2025: $285.58M$285.58M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$285.58M+97.1%
2024$144.86M-34.5%
2023$221.12M+358.5%
2022$48.23M-51.9%
2021$100.30M+1175.4%
2020$7.86M-87.4%
2019$62.33M+44.9%
2018$43.01M+38.1%
2017$31.14M+13.8%
2016$27.36M-82.3%
2015$154.68M-8.5%
2014$169.04M+1422.2%
2013$11.11M+100854.5%
2012$11.0K—
2011$0-100.0%
2010$38.16M+27.8%
2009$29.86M+153.9%
2008$11.76M—